Advertisement
U.S. markets closed
Advertisement

Cronos Group Inc. (CRON)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
2.1900+0.0900 (+4.29%)
At close: 04:00PM EST
2.1900 0.00 (0.00%)
After hours: 07:51PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Performance Outlook
Previous Close2.1000
Open2.0400
Bid2.1700 x 21500
Ask2.2000 x 3000
Day's Range2.0272 - 2.2000
52 Week Range1.6400 - 3.6160
Volume4,061,051
Avg. Volume2,347,447
Market Cap834.64M
Beta (5Y Monthly)1.38
PE Ratio (TTM)N/A
EPS (TTM)-0.3100
Earnings DateFeb 26, 2024 - Mar 01, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.82
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CRON

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Cronos Group Inc. Common Share
    Analyst Report: Cronos Group Inc.Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.
    Rating
    Fair Value
    Economic Moat
    15 days agoMorningstar
View more
  • InvestorPlace

    3 Underperforming Cannabis Stocks You Better Not Be Buying

    In an August 2023 column, I wrote “With the chances of marijuana companies accessing the U.S. financial system higher than ever and cannabis stocks trading at lower valuations than ever before, now looks like an excellent time to seek out top-notch cannabis stocks to buy.” I also identified three cannabis companies with very attractive valuations and strong outlooks. However, despite the fact that cannabis stocks in general had tumbled over 90% from their February 2021 peak as of October 2023, t

  • GlobeNewswire

    Cronos Group Inc. enters into agreement for the sale-leaseback of its Stayner, Ontario facility

    TORONTO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that its wholly owned subsidiary entered into an agreement (the “Sale Agreement”) with Future Farmco Canada Inc. (the “Buyer”), a vertical farming company, for the sale and leaseback of its property located at 4491 Concession 12 Sunnidale Road, Stayner, Ontario, Canada, L0M 1S0 (the “Peace Naturals Campus”). Pursuant to the terms of the Sale Agreement, the Buyer has

  • InvestorPlace

    The 7 Most Undervalued Penny Stocks to Buy Now: November 2023

    The year has been a mixed bag for undervalued penny stocks as investors continue to remain cautious. I believe that even 2024 will be a year of careful stock selection than a broad-based rally across sectors and stocks. If we look at the positives, potential rate cuts in the second half of next year can boost market sentiments. However, the macroeconomic headwind sustains. Overall, my strategy would be to remain overweight on blue-chip dividend stocks. I would look at 30% to 40% portfolio exposu